SZShu Zhang

Shu Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shu Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Akiko Koide

    Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016

    1 shared publication
  • Ankit Gupta

    Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016

    1 shared publication
  • Demet Araç

    University of Chicago

    1 shared publication
  • Elizabeth Ruvalcaba

    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    1 shared publication
  • Eric Pickering Boorman

    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    1 shared publication
  • Gabriel S. Salzman

    Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA

    1 shared publication

Latest Publications

  • Accessible Care with High Patient Satisfaction: Telemedicine Use in Sickle Cell Disease

    by Shu Zhang, Wingel Xue, Eric Pickering Boorman, Elizabeth Ruvalcaba, Mandy David, Sophie Miriam Lanzkron, Michelle Nuttall Eakin

    Background: The COVID-19 pandemic necessitated a rapid transition to telemedicine, providing a critical opportunity to study telemedicine satisfaction and usability in patients with sickle cell disease (SCD). Methods: A cross-sectional survey was completed by 99 adult SCD patients who participated in at least one telemedicine visit between March and July 2020. Telemedicine satisfaction and usability were assessed with the Telemedicine Satisfaction Questionnaire (TSQ) and System Usability Scale (SUS), respectively. Preference for video visits was assessed with a 1–10 rating scale, with 10 indicating the highest preference. Measures of anxiety, depression, and patient activation were also assessed. Linear and logistic regressions were performed to evaluate for socioeconomic and psychosocial correlates of telemedicine satisfaction, usability, and preference. Results: Participants were 72% women, with a mean age of 39 years. The median (interquartile range [IQR]) TSQ was 56 (52–64) out of 70, indicating high satisfaction. The median (IQR) SUS was 72.5 (62.5–82.5) out of 100, indicating above average usability. Participants tended to prefer video visits for regular care (median [IQR] rating of 7 [5–9]) but not for management of acute pain (median [IQR] rating of 4 [2–8]). Neither satisfaction nor usability was associated with age or mental health. Telemedicine usability was positively associated with having private insurance compared with public insurance. Higher scores on both satisfaction and usability were associated with higher patient activation. Conclusions: Adults with SCD report good usability and high satisfaction with telemedicine, across multiple demographic groups. Therefore, telemedicine has valuable potential to improve access to high-quality care for these patients.


  • Stachel-independent modulation of GPR56/ADGRG1 signaling by synthetic ligands directed to its extracellular region

    by Gabriel S. Salzman, Shu Zhang, Ankit Gupta, Akiko Koide, Shohei Koide, Demet Araç

    Adhesion G protein-coupled receptors (aGPCRs) play critical roles in diverse biological processes, including neurodevelopment and cancer progression. aGPCRs are characterized by large and diverse extracellular regions (ECRs) that are autoproteolytically cleaved from their membrane-embedded signaling domains. Although ECRs regulate receptor function, it is not clear whether ECRs play a direct regulatory role in G-protein signaling or simply serve as a protective cap for the activating “Stachel” sequence. Here, we present a mechanistic analysis of ECR-mediated regulation of GPR56/ADGRG1, an aGPCR with two domains [pentraxin and laminin/neurexin/sex hormonebinding globulin-like (PLL) and G protein-coupled receptor autoproteolysis-inducing (GAIN)] in its ECR. We generated a panel of high-affinity monobodies directed to each of these domains, from which we identified activators and inhibitors of GPR56-mediated signaling. Surprisingly, these synthetic ligands modulated signaling of a GPR56 mutant defective in autoproteolysis and hence, in Stachel peptide exposure. These results provide compelling support for a ligand-induced and ECR-mediated mechanism that regulates aGPCR signaling in a transient and reversible manner, which occurs in addition to the Stachel-mediated activation. Significance G protein-coupled receptors enable cells to sense extracellular signals and translate them into physiological responses. In addition to a transmembrane domain that transduces signals into the cytoplasm, adhesion G protein-coupled receptors (aGPCRs) have large extracellular regions (ECRs) that interact with proteins in the extracellular space. The goal of this study is to elucidate how ECRs control aGPCR activation. We engineered synthetic binding proteins, termed monobodies, that bind specific domains in the ECR and showed that monobodies can activate or inhibit G-protein signaling. Our data conclusively establish the feasibility of controlling aGPCR signaling using ECR-targeted drug-like molecules and support a model in which ligand binding to the ECR can affect the transmembrane domain and modulate signal transduction.